U.S. states filed a lawsuit accusing 20 drug companies including Teva Pharmaceuticals USA Inc of a sweeping scheme to inflate drug prices – sometimes by more than 1,000 percent – and stifle competition for generic drugs, state prosecutors said on Saturday.
